Cocrystal Pharma, Inc. (COCP) Misses Q3 EPS by 18c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.70), $0.18 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• HSBC explains why risk assets continue to ignore every negative catalyst
• HSBC Raises S&P500 Target to 8,100